loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Anagrelide Hydrochloride

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Anagrelide Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 87,528Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules
    Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules

    24 May 2022

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/teva-issues-voluntary-nationwide-recall-one-lot-anagrelide-capsules-usp-05-mg-due-dissolution-test

    FDA
    24 May 2022
    Share Share
    Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Anagrelide Capsules
    Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Anagrelide Capsules

    10 Dec 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/torrent-pharmaceuticals-limited-issues-voluntary-nationwide-recall-of-anagrelide-capsules-1607675919.pdf

    FDA
    10 Dec 2020
    Share Share
    Enforcement Report - Week of December 9, 2020
    Enforcement Report - Week of December 9, 2020

    09 Dec 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-9-2020-1607497312.pdf

    FDA
    09 Dec 2020
    Share Share
    Enforcement Report - Week of September 25, 2019
    Enforcement Report - Week of September 25, 2019

    26 Sep 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-25-2019-1569469631.pdf

    FDA
    26 Sep 2019
    Share Share
    Mylan's Anagrelide Receives Approval In Europe
    Mylan's Anagrelide Receives Approval In Europe

    01 Mar 2018

    // EMA

    https://www.pharmacompass.com/pdf/news/mylans-anagrelide-receives-approval-in-europe-1519884132.pdf

    EMA
    01 Mar 2018
    Share Share
    Seven medicines recommended for approval, including an advanced therapy
    Seven medicines recommended for approval, including an advanced therapy

    16 Dec 2017

    // EMA

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/12/news_detail_002867.jsp&mid=WC0b01ac058004d5c1

    EMA
    16 Dec 2017
    Share Share